SUBSCRIBERS

QT Vascular sells IP rights for its coronary products to US firm

Published Thu, May 24, 2018 · 09:50 PM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

Singapore

MEDTECH firm QT Vascular on Thursday said it has entered into an asset purchase-and-option agreement with Teleflex Life Sciences Unlimited Company and New York-listed Teleflex Incorporated to sell the firm's intellectual property rights to its non-drug coated coronary products, including Chocolate XD and Glider.

The deal also provides Teleflex with an option to purchase the drug coated coronary balloon catheter, known as Chocolate Heart, which is now being developed.

Copyright SPH Media. All rights reserved.